Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis

NCT03050151 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
176
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Regeneron Pharmaceuticals

Collaborators